Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans.

Fleroxacin (Ro 23-6240; AM-833) is a new trifluorinated quinolone exhibiting high activity against a broad spectrum of gram-negative and gram-positive bacteria. Healthy male volunteers received, according to a randomized scheme, oral doses of 200, 400, or 800 mg of fleroxacin in tablet form, an intr...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Weidekamm, E, Portmann, R, Suter, K, Partos, C, Dell, D, Lücker, P W
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1987
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC175826/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3125788/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.12.1909
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!